Are you interested in joining a clinical research trial for psilocybin? Here are five things to know about what to expect and how to get involved in psilocybin research studies.
Post-traumatic stress disorder symptom improvement lasting years after MDMA-assisted psychotherapy. Principal Investigator Dr. Michael Mithoefer talks about the treatment approach and factors influencing the treatment response.
While there is a large focus today on substances and the experience of taking them, much of the healing potential these drugs offer comes through the integration of the experience afterwards. In this article, Brian Murphy, MEd, LCSW shares advice and insight into making the most of integration - whether your experience was over- or underwhelming - and generating the most healing for ourselves and our wider community.
These uncertain times have placed us all on a collective journey that can open us up to healing. Learn from Safa Boga about her patients' experiences.
You could be eligible to participate in a psychedelic research trial. We’ve compiled a list here of all the current or planned clinical trials on MDMA, psilocybin, LSD, ibogaine, and more.
Finding the best fit therapist for you can be a daunting task, whether or not the work involves psychedelics. In this article, we share insights into finding the best therapist for you - navigating the degrees of health professionals, reflecting on your own needs, listing questions to ask when interviewing a therapist, and more.
Explore the opportunities and risks of legal ways to pursue psychedelic experiences through four options outlined in this article.
Psychedelic therapy can benefit individuals with PTSD, but can it also help couples better deal with this condition? Randy Lail enters MDMA-assisted psychotherapy treatment with his partner and participates in an MDMA study focused on couples. “After the division, the two parts of man, each desiring his other half, came together, and throwing their arms
The Food and Drug Administration (FDA) and the National Institutes of Health (NIH) communicated publicly about psychedelic drug development and current thinking around safety, therapeutic use, and research. The FDA Division of Psychiatry Products provided information in a workshop about how to design and efficiently study psychedelics for potential medical use.
Six phase 2 trials investigated MDMA-assisted psychotherapy for treatment of PTSD. Results that led to Breakthrough Therapy designation are now published.
Psychedelic therapy holds a lot of promise, which medicine is right for you? Dr. Raquel Bennett describes her journey to find ketamine assisted psychotherapy and launch the first ketamine specific conference. She talks about different methods and approaches used in ketamine therapy. After struggling for over a decade with severe depression, Raquel Bennett turned to